NuLoch Resources, Inc., founded in 2005 and headquartered in Calgary, Alberta, is a rapidly growing oil and gas company engaged in petroleum and natural gas exploration, development and production within Canada and the United States. In late May 2010, NuLoch was producing at a rate of 1,100 boe/d. The company is focused on actively expanding and developing its strategic properties in North Dakota and Saskatchewan containing the widely recognized Bakken Shale and the Three Forks Sanish formations of the mid-continental Williston Basin. Considered one of the best oil plays in the U.S., the Bakken formation is the largest continuous oil formation ever assessed by the United States Geological Survey, estimated to hold up to 4.3 billion barrels of technically recoverable oil. Following a series of land and production acquisitions in the past two years, NuLoch currently has a total of approximately 64,500 producing and undeveloped net acres prospective for high-quality light and medium Bakken and Sanish oil, consisting of largely contiguous properties at Tableland in southeast Saskatchewan, and Burke and Divide Counties in North Dakota. During 2010, the company plans to drill 13 wells (9.4 net) in Tableland and 34 (3.3) wells in North Dakota. In addition, the company has oil and gas properties in southern and central Alberta, including the Enchant project with an oil discovery well, as well as the Balsam project with two oil wells in the Peace River Arch area.

The company’s robust oil-focused drilling program bodes well for intensified interest in NLR shares and an improving valuation reflective of its sizeable land position and growing production in one of the fastest-growing oil-producing areas in North America. The management expects to exit 2010 and 2011 with production levels of 1,800 boe/d and 2,600 boe/d, respectively. NuLoch shares trade on the TSX Venture Exchange in Canada and since May 2010 on the OTCQX.

OriginOil, Inc., founded in 2007 and based in Los Angeles, is a development stage company focusing on breakthrough technology to produce biofuel from algae, replacing petroleum in various applications, such as diesel, gasoline, jet fuel, plastics and solvents. The Company has developed numerous laboratory-proven, patent-pending technologies addressing typical challenges that occur in algae feeding, growth and extraction stages and improving profitability of the production process. The Company has a partnership with the U.S. Department of Energy’s Idaho National Laboratory, which recently resulted in the completion of Phase 1 of a Cooperative Research and Development Agreement (CRADA), as well as a collaboration with Desmet Ballestra, an international leader in oil and fats technologies.
Much of the world's oil and gas is made up of ancient algae deposits. Algae act as a highly efficient biological factory capable of taking carbon dioxide (CO₂), a waste product, and converting it into a high-density liquid form of natural oil through photosynthesis. Algae cells can contain up to 60% oil that can be refined into liquid fuels.
The Company is in the preliminary stages of internationally commercializing its scalable algae-to-oil technology by licensing it to customers, such as fuel refiners, and chemical and oil companies. It is currently ramping up to pilot stage and is in late stage negotiations with multi-national distribution partners. The Company plans to sell its technology through this network, both as integrated technology and as branded devices, and to offer its services to help design, build and manage algae installations worldwide.

Waytronx, Inc. (the “Company”), founded in 1998 and headquartered in Tualatin, Oregon, is a manufacturer of electromechanical component products with a focus on commercialization of advanced technologies, including its revolutionary proprietary thermal management solution developed for a broad range of microelectronics applications. The Company has made the transition from a research and development firm to an operating company generating positive EBITDA. In addition, its program of in-licensing technologies providing needed solutions for identifiable markets gives Waytronx potential for rapidly expanding revenues and significant earnings in coming years. Waytronx’ market capitalization is only 1.0 times projected 2009 revenue and less than 0.6 times projected 2010 revenue. The Company has the potential to achieve profitability late next year, and the shares are currently trading at about 5 times potential earnings for 2011 and less than 3 times potential earnings for 2012.
The Company’s patented WayCool™ and WayFast™ technology addresses the performance-limiting issue of intense heat generated by electronic systems, referred to as microwarming. Its openly licensable, fully scalable and cost effective architecture is designed to provide optimal cooling, communications and current transition for a wide range of microelectronic components used in the semiconductor, electronic packaging, solar energy, medical device and automotive industries. The Company is implementing a broad intellectual property licensing program expected to yield worldwide license and royalty agreements, focusing on 3D-stacked integrated circuit applications. Through its wholly owned subsidiaries, CUI, Inc. (“CUI”) and CUI Japan Ltd (“CUI-Japan”), acquired in May 2008 and July 2009 respectively, the Company also provides electronic components to OEMs in various industries. Integrating manufacturing, sales and distribution, as well as R&D capabilities in the U.S. and Japan, the Company created a comprehensive platform for effective global product introductions, cross-market penetration, rapid revenue growth and numerous operating synergies. In addition to the acquired revenue-generating legacy products, the Company is aggressively pursuing commercialization of novel in-licensed high-margin technologies, including two recently launched lines of encoders, C14 and AMT, resulting in distributor relationships withDigi-Key Corporationand MicroMo Electronics, Inc. of the Faulhaber Group, and a digital power module targeting telecom and LED OEMs. The Company is also preparing to launch an industry-first intra-pipeline measurement device for the natural gas industry.

Pressure BioSciences, Inc., a technology-driven life sciences company headquartered in South Easton, Massachusetts, is engaged in the research, development and commercialization of products based on pressure cycling technology (PCT). PCT is a unique platform technology that is revolutionizing the sample preparation process in biological research and other scientific analyses. PCT uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. The Company, which began significant operations in 2005 and is a successor of Boston Biomedica, Inc. (also founded by Pressure BioSciences President & CEO Richard Schumacher) currently holds 13 U.S. and 6 foreign patents covering multiple PCT applications in the life sciences, including genomic and proteomic sample preparation, pathogen inactivation, the control of enzymatic and other chemical reactions, immunodiagnostics and protein purification. It sells and installs pressure generating instruments (“Barocyclers”) with consumable accessories and reagent kits, and additionally generates revenues from instrument service contracts and replacement parts, as well as NIH and other grants. Its PCT-based products and applications are targeted for the mass spectrometry, enzymology, biomarker discovery, soil and plant biology, histology, forensics and counter-bioterror markets. The Company has already seen early market traction; current customers include researchers at more than 75 academic laboratories, government agencies, and biotechnology, pharmaceutical and other life sciences companies in the U.S. and abroad, such as Amgen, Novartis, Lilly, Pacific Northwest National Laboratory, NIH, FDA, FBI, USDA, Harvard, and NYU.

Options Media Group Holdings, Inc., www.OptionsMedia.com, founded in 2008 and headquartered in Boca Raton, Florida, is a full-service provider of leading-edge multi-channel marketing solutions to corporate brand advertisersand marketing firms. The company provides e-mail, postal and mobile SMS campaign solutions, including lead generation, data management, deliverability and video search engine optimization (SEO), banner advertising, as well as content writing and creative design services. As an applications service provider (ASP), the company offers its 1Touch Marketing (1TM) platform with access to software, hardware, bandwidth, and domains and IP addresses, as well as the ability to upload and manage prospecting lists of over 150 million consumer and 21 million business records, review and upload campaigns, and track results. The company’s clients currently send over 100 million e-mails daily. It also designs custom in-house solutions for companies that own or license large customer lists, including installation, set up, maintenance of software platform, and platform management for clients with own technical infrastructure. The company’s client s include AT&T, Dell, Disney, Fox, Texas Instruments, US Navy and NYPD. Currently, the company has an annual revenue run rate of nearly $9 million with approximately 70% gross margins and anticipates to increase it to $25 million within 12 months, assuming planned technology and database investments. The company is well positioned to capitalize on the emergent shift away from high-cost media, such as TV and print, towards more affordable and effective forms of advanced digital and internet marketing.

The American Energy Group, Ltd., (American Energy), headquartered in Westport, Connecticut, has engaged in acquisition of oil and gas properties since 1995. It owns an 18% overriding royalty interest in the Yasin Concession Block (2768-7) in Pakistan, located approximately 230 miles northeast of the port city of Karachi, and a non-producing working interest in an oil and gas lease in Galveston County, Texas. Based on geological data gathered in recent years, which suggest nearly identical structures with those of the other countries of the Arabian Peninsula, and based upon a favorable regulatory environment for foreign energy investment, a significant number of well known international oil and gas operators have moved into Pakistan.

USA Technologies, Inc., founded in 1992 and headquartered in Malvern, Pennsylvania, is a leading supplier of networked devices and associated wireless non-cash payments, including intelligent vending, as well as energy management products. Its networked products and associated services enable the owners and operators of distributed assets, such as vending machines, personal computers, copiers, faxes, kiosks, and laundry equipment the ability to offer their customers alternative cashless payment options. It also offers owners and operators remote monitoring, control and reporting on the results of these distributed assets. The Company’s energy management products reduce the power consumption of various equipment, such as refrigerated vending machines and glass front coolers. USA Technologies markets its products through direct sales, distributors, channel sales and licensing. The Company has strategic relationships with MasterCard, Coca Cola Enterprises, AT&T, First Data, Blackboard, ViVOtech, and Sony. We believe the Company, supported by 69 patents (27 patents pending), is uniquely positioned to take advantage of the anticipated dramatic growth of the networked devices sector. It currently has 35,000 ePort® intelligent vending installations in a total domestic vending market of 8 million units. The Company has an estimated 6,000 laundry installations and about 1,000 other installations (business centers and kiosks). We believe the shares, trading on the NASDAQ under the symbol USAT, offer a rare opportunity to participate in a small company that has a dominant position, aided by key strategic relationships, in a rapidly growing and potentially large market. As the anticipated rapid growth in terminal placements leads to climbing recurring revenues and as manufacturing and overhead cost reductions lead to improving margins, the Company is expected to achieve profitability in fiscal 2010.

Elephant Talk Communications, Inc., www.elephanttalk.com, founded in 1994 and headquartered in the Netherlands, is an international telecom operator and enabler/ systems integrator providing business-to-business telecommunications and content services to the multimedia industry in the United States, Europe, Asia Pacific and the Middle East. The company's sophisticated network consists of fixed-line telecommunications licenses, mobile access agreements and network interconnections with numerous national telecom incumbents and various other partnerships. To complement its international capabilities, the company has facilities in Hong Kong and Los Angeles. By combining fixed line and wireless access services with an unrestricted number of first/last mile telecom providers, the company is able to offer innovative mobile, content, voice-over-Internet protocol (VoIP) and media streaming, as well as traditional telecom services including carrier (pre) select, premium rate, shared-cost and toll-free services. The company also develops in-house telecom and media related systems and software, including MediaPhone, an advanced telecommunication soft phone and content distribution engine. The company’s network traffic is centrally managed by the company?s proprietary IN (Intelligent Network) - CRM (Customer Relationship Management) - Billing platform. In addition, operating as a Mobile Virtual Network Enabler (MVNE), the company has positioned itself as the premier outsourcing partner for both Mobile Network Operators (MNOs) and Mobile Virtual Network Operators (MVNOs).

Clearly Canadian Beverage Corporation, d/b/a Clearly Canadian Brands (the “Company”), www.clearly.ca, founded in 1988 and headquartered in Toronto, is a diversified branded food and beverage company focusing on the selection, packaging and distribution of healthy, natural and organic products. The Company operates three divisions encompassing (i.) Clearly Canadian® premium alternative beverages; (ii.) My Organic Baby and My Organic Toddler foods; (iii.) and dried fruit and nut snacks under SunRidge Farms, Naturalife, Sweet Selections, Simply by Nature and Glengrove Organics brands. The Company’s products are distributed through a network of wholesalers in Canada, the U.S., and various other countries, and are available at some of the world’s largest retailers, such as Wal-Mart, Whole Foods, Safeway, Loblaws, Sobey's, 7-Eleven, Shell Convenience Stores, Babies "R" Us and others. Having completed the integration of two major acquisitions over the past 18 months, consolidating operations and centralizing personnel, the Company has now created a strong platform to capitalize on operational efficiencies and strategic opportunities to grow its business through continued organic growth, persistent product innovation and synergistic acquisitions. Trading on the OTC Bulletin Board under the symbol CCBEF, the Company appears well positioned to become a niche player in the emerging organic and natural food and beverage sector.

China INSOnline Corp., incorporated in Delaware and headquartered in Beijing, is a rapidly growing licensed insurance agency in the People’s Republic of China. The Company operates a leading insurance industry web portal, www.soobao.cn, providing a comprehensive community forum for Chinese consumers, agents and insurance companies. Licensed by China Insurance Regulatory Commission, the Company represents major insurance underwriting firms in China offering a variety of popular personal and property insurance products, including vehicle, real estate, life and health insurance policies for a burgeoning internet-savvy middle-class population of approximately 200 million. The Company also provides advertising, website construction, software development and other services for agents and insurance companies, as well as industry news circulation and statistical analysis services for its members.

China Infrastructure Investment Corporation, incorporated in Nevada and headquartered in Henan, China, focuses on investing in, constructing, operating and managing development projects providing high quality infrastructure services and promoting regional economic growth in the People’s Republic of China (PRC).

Nymox Pharmaceutical Corporation (www.nymox.com), headquartered in Hasbrouck Heights, New Jersey and in Montreal, Canada, is a diversified biopharmaceutical research and development company with an extensive portfolio of patented technologies for proprietary therapeutic and diagnostic products targeting primarily the unmet medical needs of the aging population. In the recent months, the Company has finalized multi-center Phase II clinical studies of an advanced drug candidate for the treatment of benign prostatic hyperplasia (BPH), an enlarged prostate condition highly prevalent among elderly men. The Company is currently actively seeking strategic partnership relationships with major pharmaceutical firms. The Company currently markets proprietary diagnostic products for Alzheimer’s disease (AD), a neurodegenerative affliction of at least 15 million aging people around the world, and test kits for tobacco use or exposure. Its diagnostic test called AlzheimAlert™ is the only commercially available non-invasive urine test for AD. AlzheimAlert™ is provided through doctors in the U.S. via the Company’s clinical reference laboratory in northern New Jersey, in U.K. through a partnering lab, and in a kit version in Europe. In addition, the Company has several promising patent-protected breakthrough programs to develop treatment for AD, including technology to target spherons, dense proteins believed to cause senile plaques, as well as to use statins, widely available cholesterol-lowering drugs appearing to inhibit inflammatory microglia and otherwise combat disease symptoms. Based on proprietary technology, the Company produces NicAlert™, a medical-setting urine or saliva test strip for rapid on-site non-invasive detection of tobacco use or exposure and an over-the-counter second-hand smoke nicotine test named TobacAlert™, used in non-medical settings, including population studies, second-hand smoke detection programs, corporate healthcare or athletics. Furthermore, the Company’s portfolio of several hundred worldwide patents and patent applications also includes several antibacterials, with a disinfectant against E.coli food contamination nearing final preparation stages before regulatory approval is sought and commercialization. Trading on NASDAQ Capital Market under the symbol NYMX, the Company is capitalizing on its over-decade-long research, emerging as a leader in diseases of the aging population.

Samson Oil and Gas Limited (“Samson” or the “Company”) (www.samsonoilandgas.com) is an Australian oil and gas company headquartered in Denver, Colorado holding an extensive portfolio of exploration and development properties in Wyoming, New Mexico, Oklahoma and North Dakota. Samson has been operating in the US since 2004, when it acquired Kestrel Energy, Inc. (“Kestrel”), a Colorado based public company with properties in the Green River Basin in Wyoming, which has gradually become the new frontier for oil and gas discoveries in the US. Currently the fastest growing gas province nationwide, the Green River Basin is expected to become one of the biggest gas producing regions in North America. The Company’s position in the US market was strengthened by subsequent acquisitions of various properties, including gas producing fields acquired from Stanley Energy Inc. (“Stanley”) in May 2006, which increased the Company’s acreage in the Green River Basin to 42,000 net acres.

During the fiscal year ended June 30, 2006, which included only one month of production from the recently acquired fields, the Company produced a cumulative of 16,837 barrels of oil and 0.42 bcf of gas totaling 0.52 bcfe. The fiscal year end revenues in 2006 reached approximately US$4,268,000, growing over 385% from about US$879,000 in 2005. The revenues in the most recent quarter ended September 30, 2006 were approximately US$1,855,000. Having significantly strengthened its proved reserve base to 23.2 bcfe as of September 30, 2006, the Company continues to expand its production, which for the fiscal 2007 year is expected to grow to around 2.1 bcfe. Listed on the Australian Stock Exchange (ASX) under the symbol SSN, the Company has a valuable inventory of assets, both currently producing and with proved undeveloped resources, positioning it to become a significant player in the robust Rocky Mountain region of the US gas and oil industry.

Linkwell Corporation, www.linkwell.us, a Florida incorporated company with principal operations in Shanghai, is a leading developer, manufacturer and distributor of healthcare related disinfectants in the People’s Republic of China (PRC). Through its 90% owned subsidiary Shanghai Likang Disinfectant High Tech Co., Ltd, a science and technology enterprise with approximately 165 employees founded by the China Army Second Military Medical University in 1988, the Company produces a wide variety of disinfectants in liquid, tablet, powder and aerosol form, as well as air sterilization devices, hot press bags, swabs and testing indicators. As one of a few nationally recognized domestic brands with rich R&D traditions, the Company’s products are marketed, sold and distributed to hospitals and medical facilities throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China. In light of recent SARS and avian flu outbreaks, particularly in Asia, which catalyzed initiatives to improve public health standards by the Chinese central government and resulted in heightened public awareness, the Company is focused on expanding its product portfolio to target the retail consumer market for disinfectants, as well as industrial, livestock, agricultural and other specialized segments of the disinfectant industry. For the first six months of 2006, the Company reported revenues of $3.3 million, a 57% increase from $2.1 million generated in a comparable period last year, and net income of $390,692 or nearly 12% net profit margin. Trading on the OTC Bulletin Board under the symbol LWLL, the Company has capitalized on its technical expertise and distribution structure to become a prominent and influential leader of the emerging disinfectant industry in China. The Company is the only publicly traded Chinese disinfectant company in the US.

Continental Energy Corporation (www.continentalenergy.com) (Continental or the “Company”) is a Dallas, Texas based independent oil and gas exploration company focused on large commercial discoveries in Indonesia. Its current prospect inventory is in the prolific Bengara-II Block, which is known for still unexploited oil and gas reserves. The Company recently signed an agreement with CNPCHK (Indonesia) Limited (CNPC) to develop Bengara-II Block. CNPC is a wholly owned subsidiary of Hong Kong listed China National Petroleum Company (Hong Kong) Limited. Continental is a Canadian issuer listed on the OTC Bulletin Board and is trading under the symbol CPPXF.

Much of Continental’s current focus is the exploration and development of its interests in the Bengara-II Block. CNPC together with its partners Continental and Resources Company (GeoPetro) has exclusive petroleum exploration and production rights to this nine hundred thousand-acre block, located in East Kalimantan, Indonesia. The East Kalimantan region (together with Aceh, Irian Jaya, Java and Sumatra) is one of the primary oil rich areas in Indonesia and currently has several oil producing basins. Its main basins include the Tarakan Basin and the Kutei Basin. The Bengara-II is located in the Tarakan Basin.

The main oil companies in East Kalimantan include Exxon/Mobil (NYSE: XOM), Total-Fina-Elf partnership, China National Offshore Oil Corp. (HK/NYSE: CNOOC), Arco (a subsidiary of British Petroleum – LSE: BP). Arco’s main focus is in smaller fields and Unocal (a Chevron company – NYSE: CVX). Unocal’s West Seno field, offshore from East Kalimantan, currently produces 14,000 bpd oil and 18 million cubic feet (MMcf) per day gas. This field is expected to produce 60,000 barrels per day of oil and 150 million cubic feet of gas per day on completion of the second phase. The region is widely believed to be highly prolific with enough reserves to host an economic oil and gas operation.

Continental can be viewed as an investment opportunity that provides speculative exposure to the oil and gas sector in Indonesia. As much of its main fields mature, future Indonesian oil output is expected to come from smaller oil fields. Economics of smaller fields generally suit smaller companies with lean cost structures, as they can remain profitable even with a relatively lower production. Continental represents the new generation of oil and gas companies in Indonesia.

Despite the relatively volatile and risky political environment as well as generally mature oil fields, Indonesia continues to attract investments from foreign companies to develop its oil resources. High oil prices (which make exploration and development worthwhile) and its proximity to fast growing Chinese and Indian economies are viewed as the main reasons behind the continued interest. The industry further benefits from its ongoing reforms instigated by the Indonesian government. Continental benefits from these reforms with favorable contract terms as well as the assurance of minimum state interference.

The recent agreement with CNPC further reduces the risk profile of Continental. CNPC is expected to develop the Bengara-II Block following an agreement with the Company and has acquired 70% of the Bengara-II project.

Brainytoys Limited (www.brainytoys.com), headquartered in Perth, Australia is a toy and game development company with a portfolio of over fifty largely market ready products in various segments of the world’s toys and games industry, with an emphasis on electronics and software technologies. Having gained significant product development expertise utilizing advanced computer graphic design tools, 3D modeling and animation technologies, as well as state-of-the-art 3D plastic printing machines for creating physical prototypes, the Company is forming strategic industry alliances in preparation for first product launches. This spring, the Company signed three marketing and distribution MOUs with established industry participants gaining access to distribution channels comprised of over 20,000 outlets in the United States, Canada, Europe, Asia, Oceania and Latin America, including major mass retailers, independent specialty stores and schools, in addition to online and catalogue offers. In order to quickly establish initial revenue streams, the Company is also seeking license agreements exploiting its portfolio properties. Listed under the symbol BRT in March 2005 as the first and only public toy and game development issue on the Australian Stock Exchange, the Company is emerging as a highly praised source of creative, innovative, new generation products for the world’s toys and games markets and youngest global consumers. The Company has announced its intention to also list its shares on the US financial markets, initially on the Pink Sheets and subsequently on the OTC Bulletin Board, and to seek synergistic acquisitions of toys and games companies in the US.

Brainstorm Cell Therapeutics, Inc., headquartered in New York City and with main R&D operations in Israel, is a development stage biotechnology company focused on developing innovative autologous adult stem cell therapies for highly debilitating incurable neurodegenerative disorders (NDDs), such as Parkinson’s disease (PD), Amyotrophic Lateral Sclerosis (ALS), sometimes called Lou Gehrig's disease, and Multiple Sclerosis (MS), among others. Since October 2004, the Company operates primarily through BrainStorm Cell Therapeutics Ltd, a wholly-owned subsidiary with 6,500 square feet of office and laboratory space in Israel. The Company’s patent-pending NurOwn™ technology is licensed from Ramot at Tel Aviv University Ltd, the technology transfer company of Tel Aviv University and enables in-vitro differentiation of bone marrow stromal stem cells into neural-like cells. NurOwn™ is based on discoveries made at the Felsenstein Medical Research Center of Tel Aviv University by a team of two world-renown scientists, a prominent neurologist Prof. Eldad Melamed, Head of Neurology at Rabin Medical Center and key advisor to Michael J. Fox Foundation, and Dr. Daniel Offen, an expert cell biologist. Using NurOwn™, the Company developed three approaches to generate functional neurons, astrocytes and oligodendrocytes for NDD transplantation treatments. The Company is currently sponsoring pre-clinical animal trials confirming the safety and efficacy of first two of its treatment approaches. Trading on the Over-the Counter Bulletin Board under the symbol BCLI, the Company is positioned to become a leader in adult stem cell transplantation for neurodegenerative diseases.

Sunwin International Neutraceuticals, Inc. (www.sunwin.biz), headquartered in Qufu, in the Shandong Province of the People’s Republic of China, is a diversified nutraceutical company engaged in the development, manufacturing and international sale of a variety of health products for humans and animals. The Company’s agricultural processing expertise and convenient access to raw materials in select Chinese farmlands result in high-quality and cost-effective natural products that straddle the healthcare industry and the food & beverage marketplace. Products offered by the Company include a powerful low-calorie natural sweetener called stevioside, numerous herbal extracts rooted in traditional Chinese medicine (TCM), as well as a variety of veterinary medicines and feed supplements. Their innovative nature has in recent years earned state-level recognition and several industry awards for the Company. For the fiscal year ended April 30, 2005, the Company’s revenues rose 11% to $12,114,006, and the net income increased 78% to $829,114, or $.02 per share. In the first nine months of fiscal 2006 ended January 31, 2006, total revenues climbed nearly 21% to $11,065,853, and net income grew 474% to $2,025,104, or $0.04. Last September, the Company completed an upgrade and expansion of most of its manufacturing facilities, which not only increased stevioside production capacity to 300 tons per year, or a double-digit percentage share of the global demand, but also fulfilled GMP requirements mandated since the beginning of 2006 by the central government on producers of Chinese herb and veterinary medicines. Trading on the OTC Bulletin Board under the symbol SUWN, the Company is well positioned to immediately capitalize on the temporary competitive advantage resulting from the GMP certification and benefit from the overall growing health concerns among consumers globally, increasing popularity of organic foods and medicines, and the strong condition of the Chinese economy.